Perbedaan Lavender Bina Cendikia Tbk. dan Diagnos Laboratorium Utama Tbk.: Lavender Bina Cendikia Tbk. diperdagangkan di Rp30 (kapitalisasi pasar 30,9 M, volume 24 jam 2,96 jt), sedangkan Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb). Perbedaan utamanya: Diagnos Laboratorium Utama Tbk. jauh lebih besar — sekitar 10,1× kapitalisasi pasar Lavender Bina Cendikia Tbk., dan Lavender Bina Cendikia Tbk. lebih aktif diperdagangkan (2,96 jt vs 963,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BMBL | DGNS | |
|---|---|---|
Kapitalisasi Pasar | 30,9 M | 310,75 M |
Volume | 2,96 jt | 963,6 rb |
Lot | 29,64 rb | 9,64 rb |
Perputaran | 88,75 jt | 217,67 jt |
Harga Rata-rata | 29,94 | 225,89 |
Nilai Transaksi | 88,75 jt | 217,67 jt |
Harga Ekuilibrium Indikatif | 30 | 226 |
Volume Ekuilibrium Indikatif | 1 | 1 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.
Selengkapnya di halaman BMBL →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →